Cell line name | PFIZi012-A |
---|---|
Synonyms | FB66c17; RCi198 |
Accession | CVCL_VE73 |
Resource Identification Initiative | To cite this cell line use: PFIZi012-A (RRID:CVCL_VE73) |
Comments | From: Pfizer, Inc. Derived from sampling site: Cell type=Fibroblast. |
Disease | Chromosome 16p11.2 deletion syndrome (NCIt: C120408) Proximal 16p11.2 microdeletion syndrome (ORDO: Orphanet_261197) |
Species of origin | Homo sapiens (Human)
(NCBI Taxonomy: 9606)
|
Sex of cell | Sex unspecified |
Age at sampling | Age unspecified |
Category | Induced pluripotent stem cell |
Cross-references | |
Cell line collections | EBiSC; PFIZi012-A
ECACC; 66540228 |
Cell line databases/resources | hPSCreg; PFIZi012-A |
Biological sample resources | BioSamples; SAMEA4097192 |
Encyclopedic resources | Wikidata; Q54947266 |
Entry history | |
Entry creation | 14-May-2018 |
Last entry update | 16-Dec-2021 |
Version number | 5 |